259 related articles for article (PubMed ID: 28185419)
1. Accumulation of rectum dose-volume metrics for prostate external beam radiotherapy combined with brachytherapy: Evaluating deformably registered dose distribution addition using parameter-based addition.
Moulton CR; House MJ; Lye V; Tang CI; Krawiec M; Joseph DJ; Denham JW; Ebert MA
J Med Imaging Radiat Oncol; 2017 Aug; 61(4):534-542. PubMed ID: 28185419
[TBL] [Abstract][Full Text] [Related]
2. Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications.
Moulton CR; House MJ; Lye V; Tang CI; Krawiec M; Joseph DJ; Denham JW; Ebert MA
Radiat Oncol; 2016 Oct; 11(1):144. PubMed ID: 27799048
[TBL] [Abstract][Full Text] [Related]
3. The influence of a rectal ultrasound probe on the separation between prostate and rectum in high-dose-rate brachytherapy.
Rylander S; Buus S; Bentzen L; Pedersen EM; Tanderup K
Brachytherapy; 2015; 14(5):711-7. PubMed ID: 26164752
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
5. Assessment of cumulative external beam and intracavitary brachytherapy organ doses in gynecologic cancers using deformable dose summation.
Teo BK; Bonner Millar LP; Ding X; Lin LL
Radiother Oncol; 2015 May; 115(2):195-202. PubMed ID: 26002306
[TBL] [Abstract][Full Text] [Related]
6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
[TBL] [Abstract][Full Text] [Related]
8. Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer.
Van de Kamer JB; De Leeuw AA; Moerland MA; Jürgenliemk-Schulz IM
Radiother Oncol; 2010 Feb; 94(2):248-53. PubMed ID: 20080309
[TBL] [Abstract][Full Text] [Related]
9. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate.
Okamoto M; Ishikawa H; Ebara T; Kato H; Tamaki T; Akimoto T; Ito K; Miyakubo M; Yamamoto T; Suzuki K; Takahashi T; Nakano T
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e211-7. PubMed ID: 21620579
[TBL] [Abstract][Full Text] [Related]
10. A method to estimate composite doses for organs at risk in prostate cancer patients treated with EBRT in combination with HDR BT.
Pettersson N; Johansson KA; Alsadius D; Tucker SL; Steineck G; Olsson C
Acta Oncol; 2014 Jun; 53(6):815-21. PubMed ID: 24460070
[TBL] [Abstract][Full Text] [Related]
11. Deformable image registration for cervical cancer brachytherapy dose accumulation: Organ at risk dose-volume histogram parameter reproducibility and anatomic position stability.
Flower E; Do V; Sykes J; Dempsey C; Holloway L; Summerhayes K; Thwaites DI
Brachytherapy; 2017; 16(2):387-392. PubMed ID: 28161434
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the total rectal dose of radical external beam and intracavitary radiotherapy for uterine cervical cancer using the deformable image registration method.
Hayashi K; Isohashi F; Akino Y; Wakai N; Mabuchi S; Suzuki O; Seo Y; Ootani Y; Sumida I; Yoshioka Y; Kimura T; Ogawa K
J Radiat Res; 2015 May; 56(3):546-52. PubMed ID: 25678538
[TBL] [Abstract][Full Text] [Related]
13. Spatial features of dose-surface maps from deformably-registered plans correlate with late gastrointestinal complications.
Moulton CR; House MJ; Lye V; Tang CI; Krawiec M; Joseph DJ; Denham JW; Ebert MA
Phys Med Biol; 2017 May; 62(10):4118-4139. PubMed ID: 28445167
[TBL] [Abstract][Full Text] [Related]
14. Structure-based deformable image registration: Added value for dose accumulation of external beam radiotherapy and brachytherapy in cervical cancer.
van Heerden LE; Houweling AC; Koedooder K; van Kesteren Z; van Wieringen N; Rasch CRN; Pieters BR; Bel A
Radiother Oncol; 2017 May; 123(2):319-324. PubMed ID: 28372889
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.
Hermesse J; Biver S; Jansen N; Lenaerts E; Nickers P
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):269-76. PubMed ID: 19775833
[TBL] [Abstract][Full Text] [Related]
16. Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
Pinkawa M; Fischedick K; Treusacher P; Asadpour B; Gagel B; Piroth MD; Borchers H; Jakse G; Eble MJ
Radiother Oncol; 2006 Jan; 78(1):41-6. PubMed ID: 16271785
[TBL] [Abstract][Full Text] [Related]
17. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
18. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of rectum and bladder dose accumulation from external beam radiotherapy and brachytherapy for cervical cancer using two different deformable image registration techniques.
Kadoya N; Miyasaka Y; Yamamoto T; Kuroda Y; Ito K; Chiba M; Nakajima Y; Takahashi N; Kubozono M; Umezawa R; Dobashi S; Takeda K; Jingu K
J Radiat Res; 2017 Sep; 58(5):720-728. PubMed ID: 28595311
[TBL] [Abstract][Full Text] [Related]
20. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
